Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | HTR7 | P34969 | 1/20 | 0.47 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.47 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.47 |
| ▸ | THRA | P10827 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9851279 | 0.98 | KDM4E (0.49) | KDM4EADRB2PTPN1HTR7SOAT1 | |
| SCHEMBL16180436 | 0.95 | KDM4E (0.51) | KDM4EADRB2PTPN1HTR7KCNA3 | |
| SCHEMBL34465293 | 0.86 | ADRB2 (0.63) | KDM4EADRB2PTPN1HTR7TP53 | |
| SCHEMBL7638760 | 0.86 | ADRB2 (0.63) | KDM4EADRB2PTPN1HTR7TP53 | |
| SCHEMBL5969665 | 0.85 | ADRB2 (0.61) | KDM4EADRB2PTPN1HTR7SOAT1 | |
| SCHEMBL9715200 | 0.85 | ADRB2 (0.61) | KDM4EADRB2PTPN1HTR7SOAT1 | |
| SCHEMBL10434829 | 0.85 | ADRB2 (0.61) | KDM4EADRB2PTPN1HTR7SOAT1 | |
| SCHEMBL13739869 | 0.85 | ADRB2 (0.61) | KDM4EADRB2PTPN1HTR7SOAT1 | |
| SCHEMBL3826240 | 0.85 | ADRB2 (0.61) | KDM4EADRB2PTPN1HTR7SOAT1 | |
| SCHEMBL13739675 | 0.85 | ADRB2 (0.61) | KDM4EADRB2PTPN1HTR7SOAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 109 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9184428-B2 | Non-aqueous electrolytes for lithium ion batteries | UCHICAGO ARGONNE LLC (US) | 2015-11-10 | — | — | US | claimed |
| US-9012096-B2 | Long life lithium batteries with stabilized electrodes | UCHICAGO ARGONNE, LLC (US) | 2015-04-21 | — | — | US | claimed |
| US-20060210883-A1 | Non-aqueous electrolytes for lithium ion batteries | THE UNIVERSITY OF CHICAGO | 2006-09-21 | — | — | US | claimed |
| US-20060199080-A1 | Novel redox shuttles for overcharge protection of lithium batteries | THE UNIVERSITY OF CHICAGO | 2006-09-07 | — | — | US | claimed |
| US-20060147809-A1 | Non-aqueous electrolyte of an alkali metal salt, a polar aprotic solvent, and an electrode stabilization additive comprising a linear, branched or cyclic hydrocarbon, other than a spirocyclic hydrocarbon, comprising at least one oxygen atom and at least one aryl, alkenyl or alkynyl group | THE UNIVERSITY OF CHICAGO | 2006-07-06 | — | — | US | claimed |
| US-12021226-B2 | Cathode materials for secondary batteries | UCHICAGO ARGONNE, LLC (US) | 2024-06-25 | — | — | US | disclosed |
| EP-3656009-B1 | MODIFIED IONIC LIQUIDS CONTAINING TRIAZINE | NOHMS TECH INC (US) | 2023-11-15 | — | — | EP | disclosed |
| CN-110915037-B | Electrolyte containing phosphorus | 诺姆斯科技公司 | 2023-11-07 | — | — | CN | disclosed |
| EP-4158671-A2 | MODIFIED IONIC LIQUIDS CONTAINING BICYCLOPHOSPHATE MOIETY | Nohms Technologies, Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| US-11575125-B2 | Patterned anode for lithium-ion batteries | UCHICAGO ARGONNE, LLC (US) | 2023-02-07 | — | — | US | disclosed |
| EP-4106070-A1 | PHOSPHORUS-CONTAINING ELECTROLYTES | Nohms Technologies, Inc. (US) | 2022-12-21 | — | — | EP | disclosed |
| US-11489201-B2 | Modified ionic liquids containing phosphorus | NOHMs Technologies, Inc. (US) | 2022-11-01 | — | — | US | disclosed |
| US-20060210883-A1 | Non-aqueous electrolytes for lithium ion batteries | THE UNIVERSITY OF CHICAGO | 2006-09-21 | — | — | US | disclosed |
| US-20060199080-A1 | Novel redox shuttles for overcharge protection of lithium batteries | THE UNIVERSITY OF CHICAGO | 2006-09-07 | — | — | US | disclosed |
| US-20060147809-A1 | Non-aqueous electrolyte of an alkali metal salt, a polar aprotic solvent, and an electrode stabilization additive comprising a linear, branched or cyclic hydrocarbon, other than a spirocyclic hydrocarbon, comprising at least one oxygen atom and at least one aryl, alkenyl or alkynyl group | THE UNIVERSITY OF CHICAGO | 2006-07-06 | — | — | US | disclosed |
| EP-0805685-B1 | NOVEL ANTIFUNGAL CYCLOHEXAPEPTIDES | MERCK & CO INC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-5854213-A | Antifungal cyclohexapeptides | MERCK & CO., INC. (US) | 1998-12-29 | — | — | US | disclosed |
| EP-0805685-A4 | NOVEL ANTIFUNGAL CYCLOHEXAPEPTIDES | MERCK & CO INC (US) | 1998-04-29 | — | — | EP | disclosed |
| EP-0805685-A1 | NOVEL ANTIFUNGAL CYCLOHEXAPEPTIDES | Merck & Co., Inc. (US) | 1997-11-12 | — | — | EP | disclosed |
| WO-1996022784-A1 | NOVEL ANTIFUNGAL CYCLOHEXAPEPTIDES | MERCK & CO., INC. (US) | 1996-08-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11489201-B2 | Modified ionic liquids containing phosphorus | INPPL1, PLCB3, INPP5D | KDM4E 3004/4885ADRB2 4817/4885PTPN1 1400/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.